老虎證券
Invest
Pricing
Rewards
Support
About
Quotes
TigerAI
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
INVESCO BIOTECHNOLOGY & GENOME ETF
94.91
-0.7598
-0.79%
盤後：
94.91
0.0000
0.00%
19:30 EDT
成交量：
1.99萬
成交額：
188.45萬
市值：
4.12億
市盈率：
52.93
高：
95.59
開：
95.59
低：
94.69
收：
95.67
52周最高：
98.82
52周最低：
67.69
股本：
434.00萬
流通股本：
434.00萬
量比：
1.80
換手率：
0.46%
股息：
1.55
股息率：
1.63%
每股收益(TTM):
1.79
每股收益(LYR):
18.65
淨資產收益率：
24.76%
總資產收益率：
0.08%
市淨率：
1.67
市盈率(LYR):
5.09
資料載入中...
總覽
公司
新聞資訊
公告
Leqembi®真實世界領先研究在AAIC® 2026發布：超75%早期阿爾茨海默病患者在平均17個月治療期內保持穩定，近7%出現改善
美股速递
·
07/14
Biogen股價下跌，因其一款實驗性阿爾茨海默病藥物未達到主要臨床試驗目標
路透中文
·
07/14
渤健公司於AAIC公布Celia二期數據：Diranersen在早期阿爾茨海默病中展現顯著臨床獲益與強勁Tau蛋白降低
美股速递
·
07/14
百健(BIIB.US)：將推進阿爾茨海默病藥物Diranersen至3期臨床。
智通财经
·
07/14
FDA批准勃健(BIIB)阿爾茨海默病新藥皮下劑型 拓展居家治療應用場景
金吾财讯
·
07/14
FDA批准Leqembi Iqlik®（lecanemab-irmb）皮下注射劑作為早期阿爾茨海默病的起始劑量
美股速递
·
07/14
美國食品藥品監督管理局批准阿爾茨海默病藥物居家使用後，百健股價上漲
路透中文
·
07/14
FDA批准Leqembi皮下注射劑型治療阿爾茨海默病的新起始給藥方案
美股速递
·
07/14
Vertex(VRTX)百億美元收購罕見病藥企 拓寬內分泌管線佈局
金吾财讯
·
07/13
英硅智能早盤升逾7% 與康哲藥業達成AI+創新藥研發新合作
新浪港股
·
07/13
福泰製藥百億美元併購透露了什麼訊號？
蓝鲸财经
·
07/11
BUZZ——美國股市動態-SK海力士、達美航空、Circle Internet
路透中文
·
07/10
滙豐表示，生物製藥領域的併購交易有望創下年度新高
路透中文
·
07/10
阿爾尼拉姆製藥公司股價大漲15.5%，因阿斯利康神經疾病藥物Wainua心臟病後期試驗失敗
美股速递
·
07/09
福泰製藥(VRTX)股票7月8日盤中下跌3.09%：投資者必看的核心信息
TradingKey中文
·
07/09
大摩解讀福泰製藥百億收購Crinetics：補齊內分泌管線佈局 兩大核心藥物打開增長空間
智通财经
·
07/08
RBC Capital上調福泰製藥目標價至570美元
格隆汇
·
07/08
（活力中國調研行）上海生物醫藥產業規模破萬億 張江藥谷青年人才成創新藥研發主力
中国新闻网
·
07/08
Vera Therapeutics股價飆升：腎病新藥獲FDA批准
投资观察
·
07/08
數據簡報-隨着競爭日趨激烈，減肥藥開發商紛紛搶佔這一利潤豐厚的市場
路透中文
·
07/07
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/PBE/news?page=7"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"PBE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","market":"US","secType":"STK","nameCN":"INVESCO BIOTECHNOLOGY & GENOME ETF","latestPrice":94.91,"timestamp":1789761600000,"preClose":95.6698,"halted":0,"volume":19855,"hourTrading":{"tag":"盘后","latestPrice":94.91,"preClose":94.91,"latestTime":"19:30 EDT","volume":11,"amount":1042.81,"timestamp":1789774205884,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.007941900160761269,"floatShares":4340000,"shares":4340000,"eps":1.793292,"marketStatus":"休市中","change":-0.7598,"latestTime":"09-18 16:00:00 EDT","open":95.59,"high":95.59,"low":94.69,"amount":1884465.847,"amplitude":0.009407,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":1.793292,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":95.6698,"sharesOutstanding":3180000,"nav":95.66478,"aum":414120917.85,"dividendRate":0.01633,"bidAskSpread":0.002296,"preHourTrading":{"tag":"盘前","latestPrice":93.38,"preClose":95.6698,"latestTime":"07:13 EDT","volume":5,"amount":466.9,"timestamp":1789730023426,"change":-2.2898,"changeRate":-0.023934,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":94.91,"preClose":94.91,"latestTime":"19:30 EDT","volume":11,"amount":1042.81,"timestamp":1789774205884,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.8031312986512782,"impliedVol":0.1158,"impliedVolPercentile":0.0398},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","floatShares":4340000,"roa":"0.08%","roe":"24.76%","lyrEps":18.654418,"volumeRatio":1.8031312986512782,"shares":4340000,"dividePrice":1.5499,"high":95.59,"amplitude":0.009407,"preClose":95.6698,"low":94.69,"week52Low":67.69,"pbRate":"1.67","psRate":"239.95","week52High":98.82,"institutionHeld":0.2552,"latestPrice":94.91,"eps":1.793292,"divideRate":0.01633,"volume":19855,"delay":0,"ttmEps":1.793292,"open":95.59,"prevYearClose":82.15,"prevWeekClose":92.91,"prevMonthClose":96.68,"prevQuarterClose":89.6486,"fiveDayClose":92.91,"twentyDayClose":96.56,"sixtyDayClose":87.3983},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBE\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"PBE","amount":0.01867,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-21","defaultRemindTime":1789997400000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-25","payableDate":"2026-09-21","currency":"USD","dateTimestamp":1789963200000,"payDate":"2026-09-25"},{"date":"2026-06-22","symbol":"PBE","amount":0.81061,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"PBE","amount":0.08244,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"PBE","amount":0.41972,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"PBE","amount":0.23409,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBE\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.1208,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-31","value":0.05552,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-30","value":0.21532,"currency":"USD"},{"executeDate":"2018-09-24","recordDate":"2018-09-25","paymentDate":"2018-09-28","value":0.00207,"currency":"USD"},{"executeDate":"2020-03-23","recordDate":"2020-03-24","paymentDate":"2020-03-31","value":0.02898,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBE\",pageSize:20,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1199762348","title":"Leqembi®真實世界領先研究在AAIC® 2026發布：超75%早期阿爾茨海默病患者在平均17個月治療期內保持穩定，近7%出現改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1199762348","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199762348?lang=zh_tw&edition=fundamental","pubTime":"2026-07-14 23:16","pubTimestamp":1784042182,"startTime":"0","endTime":"0","summary":"Leqembi®真实世界领先研究在AAIC® 2026年会上公布的数据显示，在该研究中，超过75%的早期阿尔茨海默病患者在接受平均17个月的治疗后病情保持稳定，同时有近7%的患者病情出现改善。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BMED","LU0889565916.HKD","IE00B894F039.SGD","LU0320765992.SGD","BK4533","LU0234570918.USD","BK4139","IE00B19Z9P08.USD","LU0109394709.USD","BK4585","PBE","IE00B19Z9Z06.USD","BK4588","BIIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651091121","title":"Biogen股價下跌，因其一款實驗性阿爾茨海默病藥物未達到主要臨床試驗目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2651091121","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651091121?lang=zh_tw&edition=fundamental","pubTime":"2026-07-14 21:33","pubTimestamp":1784036033,"startTime":"0","endTime":"0","summary":"BUZZ-Biogen股价下跌，因其一款实验性阿尔茨海默病药物未达到主要临床试验目标7月14日-** 制药公司百健（Biogen，BIIB.O）股价下跌3.9%，收于196.45美元** 该公司表示，其用于治疗阿尔茨海默病的实验性药物迪拉纳森（diranersen）未能达到中期临床试验的主要目标，该试验旨在验证更高剂量是否能为早期阿尔茨海默病患者带来更大疗效** 但公司表示，该药物在试验中减缓了患","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nL4T43G1IJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIIB","BK4532","LU0234570918.USD","IE00B894F039.SGD","IE00B19Z9P08.USD","LU0109394709.USD","BK4585","BK4588","BMED","IE00B19Z9Z06.USD","LU0320765992.SGD","BK4139","BK4533","LU0889565916.HKD","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132952984","title":"渤健公司於AAIC公布Celia二期數據：Diranersen在早期阿爾茨海默病中展現顯著臨床獲益與強勁Tau蛋白降低","url":"https://stock-news.laohu8.com/highlight/detail?id=1132952984","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132952984?lang=zh_tw&edition=fundamental","pubTime":"2026-07-14 21:16","pubTimestamp":1784034993,"startTime":"0","endTime":"0","summary":"渤健公司近日在阿尔茨海默病协会国际会议上公布了其候选药物Diranersen的Celia二期研究数据。结果显示，该药物在治疗早期阿尔茨海默病患者时，不仅带来了具有临床意义的积极结局，更实现了Tau蛋白水平的强劲降低。这一积极信号为针对这一复杂神经退行性疾病的靶向治疗带来了新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0320765992.SGD","IE00B19Z9Z06.USD","IE00B19Z9P08.USD","BK4532","IE00B894F039.SGD","LU0109394709.USD","BIIB","LU0234570918.USD","LU0889565916.HKD","BK4139","PBE","BK4533","BMED","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651106049","title":"百健(BIIB.US)：將推進阿爾茨海默病藥物Diranersen至3期臨床。","url":"https://stock-news.laohu8.com/highlight/detail?id=2651106049","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651106049?lang=zh_tw&edition=fundamental","pubTime":"2026-07-14 21:15","pubTimestamp":1784034918,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00B19Z9P08.USD","BK4585","LU0234570918.USD","BK4139","PBE","IE00B894F039.SGD","BMED","BK4588","LU0889565916.HKD","BK4533","IE00B19Z9Z06.USD","LU0320765992.SGD","BK4532","LU0109394709.USD","BIIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651754101","title":"FDA批准勃健(BIIB)阿爾茨海默病新藥皮下劑型 拓展居家治療應用場景","url":"https://stock-news.laohu8.com/highlight/detail?id=2651754101","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651754101?lang=zh_tw&edition=fundamental","pubTime":"2026-07-14 16:31","pubTimestamp":1784017876,"startTime":"0","endTime":"0","summary":"本次剂型获批基于严谨的临床对比数据，临床试验证实，Leqembi皮下注射剂型的治疗效果、药效稳定性与原有静脉注射剂型高度一致，疗效水平无显著差异。","market":"us","thumbnail":"https://static.szfiu.com/news/20250107/NDk1MmZiNjQzNDA1OTQ5NDMzMQ==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NDk1MmZiNjQzNDA1OTQ5NDMzMQ==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302523","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","BIIB","IE00B19Z9Z06.USD","LU0320765992.SGD","LU0889565916.HKD","ESALF","ESAIY","BK4532","IE00B19Z9P08.USD","BK4585","BK4588","LABU","BK4007","BMED","LU0109394709.USD","PBE","BK4139","BK4533","IE00B894F039.SGD","MNTL","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191345039","title":"FDA批准Leqembi Iqlik®（lecanemab-irmb）皮下注射劑作為早期阿爾茨海默病的起始劑量","url":"https://stock-news.laohu8.com/highlight/detail?id=1191345039","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191345039?lang=zh_tw&edition=fundamental","pubTime":"2026-07-14 05:37","pubTimestamp":1783978636,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）已批准Leqembi Iqlik®（lecanemab-irmb）皮下注射剂，作为治疗早期阿尔茨海默病的起始剂量方案。这一决定为患者提供了一种新的、便捷的给药选择，有望改善治疗的可及性与依从性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00B19Z9Z06.USD","IE00B19Z9P08.USD","BK4533","PBE","BMED","LU0889565916.HKD","BK4139","LU0234570918.USD","LU0320765992.SGD","LU0109394709.USD","BK4532","BK4585","BIIB","IE00B894F039.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651146264","title":"美國食品藥品監督管理局批准阿爾茨海默病藥物居家使用後，百健股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2651146264","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651146264?lang=zh_tw&edition=fundamental","pubTime":"2026-07-14 02:24","pubTimestamp":1783967098,"startTime":"0","endTime":"0","summary":"BUZZ-美国食品药品监督管理局批准阿尔茨海默病药物居家使用后，百健股价上涨7月13日-** 制药公司百健（Biogen，BIIB.O）股价上涨5.3%，至209.69美元** 美国食品药品监督管理局（FDA）批准了卫材（Eisai）与百健（Biogen）联合开发的阿尔茨海默病药物Leqembi的皮下注射起始剂量方案，允许患者在家中开始治疗** 此前，Leqembi仅获批采用静脉注射起始剂量方案，","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nL4S43F1HS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z9P08.USD","BK4585","BMED","LU0889565916.HKD","IE00B19Z9Z06.USD","BK4588","LU0234570918.USD","BK4533","PBE","BK4532","LU0320765992.SGD","LU0109394709.USD","BIIB","BK4139","IE00B894F039.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120715125","title":"FDA批准Leqembi皮下注射劑型治療阿爾茨海默病的新起始給藥方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1120715125","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120715125?lang=zh_tw&edition=fundamental","pubTime":"2026-07-14 02:08","pubTimestamp":1783966119,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）已批准Leqembi皮下注射剂型用于治疗阿尔茨海默病的新起始给药方案。这一监管决定为患者提供了更便捷的治疗选择，有望改善用药依从性。\nLeqembi由渤健公司（Biogen）与合作伙伴共同开发，此次新方案的获批标志着其在阿尔茨海默病治疗领域取得了又一重要进展。皮下注射剂型相较于静脉输注，能简化给药流程，为患者和护理人员带来便利。\n新起始剂量方案的确定基于临床数据，旨在优化治疗效果并管理潜在风险。随着全球阿尔茨海默病患者数量持续增长，此类创新疗法的推进对满足未竟医疗需求具有重要意义。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z9P08.USD","IE00B894F039.SGD","PBE","BK4585","BIIB","BK4532","LU0109394709.USD","LU0234570918.USD","BK4588","BK4533","LU0889565916.HKD","BMED","LU0320765992.SGD","IE00B19Z9Z06.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651117599","title":"Vertex(VRTX)百億美元收購罕見病藥企 拓寬內分泌管線佈局","url":"https://stock-news.laohu8.com/highlight/detail?id=2651117599","media":"金吾财讯","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651117599?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 22:10","pubTimestamp":1783951848,"startTime":"0","endTime":"0","summary":"金吾财讯 | Vertex Pharmaceuticals 与 Crinetics Pharmaceuticals 共同披露收购协议，企业将以每股 85 美元现金完成标的全额收购，交易对应 Crinetics 整体股权价值约 100 亿美元，扣除标的账面现金后净交易对价 88 亿美元，交易预计 2026 年第三季度完成，消息落地后 Crinetics 盘后股价实现翻倍上涨。Vertex 计划依托自有现金搭配债务工具完成交易资金筹措，美国银行、摩根士丹利提供 45 亿美元全额过渡性融资，收购落地后企业罕见病内分泌赛道产品矩阵将实现大幅扩容。","market":"other","thumbnail":"https://static.szfiu.com/news/20210625/NjJmZjg2MTAxNTM3NTgyMzkx.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/NjJmZjg2MTAxNTM3NTgyMzkx.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302497","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","LU2362541273.HKD","SG9999013999.USD","LU1778281490.HKD","BK4532","LU2362541513.USD","IE00BFTCPJ56.SGD","IE00B19Z3581.USD","LU1585245621.USD","IDNA","LU2362540622.SGD","BK4588","BK4585","LU0757428866.USD","IE00BZ9MQY76.HKD","VRTX","BBH","LU0109394709.USD","SG9999001176.SGD","IE0002141913.USD","LU1674673428.USD","VERX","IE00B19Z9Z06.USD","LU0234570918.USD","LU0079474960.USD","LU0256863811.USD","PBE","LU1035775433.USD","LU2237438978.USD","LU0061475181.USD","LU2417539215.USD","IBB","IE00B894F039.SGD","LU1069344957.HKD","LU1093756325.SGD","LU2456880835.USD","BK4007","IBBQ","IE00B4R5TH58.HKD","IE0002270589.USD","CRNX","IE0009355771.USD","SG9999001176.USD","LU0889565916.HKD","LU0432979614.USD","BIB","LU0566484027.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651162210","title":"英硅智能早盤升逾7% 與康哲藥業達成AI+創新藥研發新合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2651162210","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651162210?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 10:02","pubTimestamp":1783908120,"startTime":"0","endTime":"0","summary":" 英硅智能早盘涨超7%，截至发稿，股价上涨6.21%，报45.48港元，成交额3.32亿港元。 7月13日，据英硅智能官微消息，公司宣布与康哲药业在中枢神经系统领域开展另一项AI驱动的药物发现合作。 根据合作协议，双方将结合英硅智能已验证的AI平台与AI赋能创新药研发能力，以及康哲药业经验丰富的研发团队和对疾病领域的深度认知，双方共同推进该研发项目的合作开发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-07-13/doc-inihrnpk9058117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["GSKH","IE00BVYPNQ40.USD","AIPO","ARTY","IE00BVYPNP33.GBP","00867","SBIO","SG9999015952.SGD","QTOC","BK4585","BK1191","IBB","VTHR","SG9999015945.SGD","WRND","AGIX","BK1593","SG9999015978.USD","CHAT","GDOC","LFSC","LU2488822045.USD","PBE","IE00BGHQDM52.EUR","BBP","BK4588","SG9999015986.USD","IE00BMCWC346.EUR","IE00BYV24P56.USD","SG9999004220.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650760159","title":"福泰製藥百億美元併購透露了什麼訊號？","url":"https://stock-news.laohu8.com/highlight/detail?id=2650760159","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650760159?lang=zh_tw&edition=fundamental","pubTime":"2026-07-11 22:55","pubTimestamp":1783781749,"startTime":"0","endTime":"0","summary":"01百亿美元级现金并购的底气福泰制药2025年全年营收120.01亿美元，同比增长9%，非GAAP净利润47.5亿美元，毛利率维持85%以上高位，账面现金及有价证券超过123亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1783569458583958068","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["IE00BJJMRZ35.SGD","LU0079474960.USD","LU0289739699.SGD","LU1093756325.SGD","BK4139","LU1069344957.HKD","BIB","IBBQ","IE00BFTCPJ56.SGD","LU0823416689.USD","LU0109394709.USD","IE00B2B36J28.USD","BK4588","LU0058720904.USD","LU2236285917.USD","LU2462157665.USD","LU0234570918.USD","LU1585245621.USD","MYLD","BK4567","SG9999001176.USD","IDNA","IE00B19Z3581.USD","IE0002270589.USD","SGXZ57979304.SGD","KCE","LU1093756168.USD","SG9999001176.SGD","LU2324357040.USD","IE00B894F039.SGD","IE00BJT1NW94.SGD","BK4532","IE0009355771.USD","IE00B19Z9P08.USD","IBB","LU0061475181.USD","LU0320765992.SGD","LU2417539215.USD","XMMO","IE00B19Z9Z06.USD","IE00BZ9MQY76.HKD","LU1778281490.HKD","IE0002141913.USD","VRTX","LU1035775433.USD","LU2362540622.SGD","CALF","IE00B4R5TH58.HKD","PBE","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650118208","title":"BUZZ——美國股市動態-SK海力士、達美航空、Circle Internet","url":"https://stock-news.laohu8.com/highlight/detail?id=2650118208","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650118208?lang=zh_tw&edition=fundamental","pubTime":"2026-07-10 19:37","pubTimestamp":1783683425,"startTime":"0","endTime":"0","summary":".N** 费米公司FRMI.O：热点 - 因发行3.75亿美元可转换债券股价暴跌nL6N43C0K8** 吉利德科学公司GILD.O:** 礼来公司LLY.N:** 艾伯维公司ABBV.N:** 百健公司BIIB.O:热点 - 汇丰银行称生物制药并购交易有望创下年度新高nL4N43C0P3** 达美航空公司DAL.N:热点 - 因预测第三季度利润将超出预期，股价上涨nL4N43C0QQ** Circle Internet Group IncCRCL.N:热点 - 获最终监管批准在美国设立信托银行后股价上涨nL4N43C0SJ** SK海力士公司SKHY.O:热点 - 筹集265亿美元后，即将迎来备受期待的美国上市nL4N43C0TG","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nL4S43C0TU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRCD","LU1868837300.USD","LU0094547139.USD","LU2756315664.SGD","IE00B42XCP33.USD","JETS","LU2133065610.SGD","LLYZ","SGXZ81514606.USD","LU1064131342.USD","SG9999015945.SGD","LU0708995401.HKD","IE00B2B36J28.USD","LU2106854487.HKD","LU1003077747.HKD","LU2750360641.GBP","LU1674673428.USD","LU0106831901.USD","IE00B19Z9Z06.USD","SG9999014906.USD","THNR","LU2168564149.EUR","LU0689472784.USD","LU1670627923.USD","LU0640476718.USD","LU2237443622.USD","BK4534","JDOC","LU1988902786.USD","LU0310799852.SGD","LU2168563687.JPY","IE0004445015.USD","LU1232071149.USD","IE0004445239.USD","LU0109391861.USD","LU0882574139.USD","CURE","LU2461242641.AUD","IE00B775H168.HKD","LU0820562030.AUD","BK4599","LU1127390331.HKD","LU0122379950.USD","BK4566","LU0823416689.USD","LU1244550494.USD","LU1670628061.USD","ELIS","LU0882574055.USD","SG9999013999.USD","LU0965509010.AUD","CRCA","FRMI","SG9999001440.SGD","SG9999018865.SGD","BKCH","LU0310800379.SGD","IE000BZT7R73.USD","LU0052756011.USD","BK4588","LU2746668974.SGD","LU0738911758.USD","LU0114720955.EUR","PPH","IE00B19Z9P08.USD","LLII","LU1778281490.HKD","ICRC","BK4581","IE00B1BXHZ80.USD","LU1989772923.USD","LU0109394709.USD","IE00BGHQF631.EUR","LU2087625088.SGD","SGXZ57979304.SGD","LU1551013425.SGD","LU0128525929.USD","IE00B1XK9C88.USD","LU0353189763.USD","SKHY","LU2168564065.EUR","CRCO","LU1934455194.USD","LU2271345857.HKD","LU1839511570.USD","SGXZ31699556.SGD","IE0000B7K699.USD","LU2471134523.USD","LU2023250330.USD","LU0912757837.SGD","IE00BWXC8680.SGD","IBLC","SG9999011175.SGD","LU1366192091.USD","LU0211328371.USD","IE00B3PB1722.GBP","LU0456855351.SGD","LU2023250504.SGD","LU1162221912.USD","LU2237443895.HKD","GILD","LU2896262040.SGD","LU2236285917.USD","IE00B7SZLL34.SGD","LU1934455277.USD","LU0889565916.HKD","SGXZ51526630.SGD","IE00B19Z3B42.SGD","SG9999003800.SGD","OZEM","LU0097036916.USD","IE00B894F039.SGD","LU0057025933.USD","LU0320765646.SGD","LU0256863902.USD","IE00B19Z3581.USD","LU2552382132.HKD","LU2456880835.USD","LU2746668461.USD","BK4533","IE00BJJMRX11.SGD","IE00BKVL7J92.USD","BK4222","IE00B3T34201.USD","LU2360107671.USD","BMED","LU0354030511.USD","IE00BJLML261.HKD","LU0029864427.USD","LU0316494557.USD","LU2756315318.SGD","ELIL","LU1861558580.USD","LU0098860793.USD","LU2468319806.SGD","LU0256863811.USD","IE000SO60NU8.SGD","SG9999001176.USD","LU0859254822.USD","LU2417539215.USD","ABBV","IE00B7KXQ091.USD","LU0861579265.USD","LU1291159041.SGD","LU0545039389.USD","LU0823434740.USD","LU0965508806.USD","LU0353189680.USD","LU2168564495.EUR","LU1074936037.SGD","LU0124676726.USD","LU1267930573.SGD","IE00BK4W5L77.USD","LU0198837287.USD","LU1861559042.SGD","BK4023","LU0006306889.USD","LU2168564222.USD","LU2023251221.USD","LU2129689431.USD","LU1917777945.USD","LU1929549753.HKD","LU1069344957.HKD","LU0096364046.USD","LU0266013472.USD","LU1093756325.SGD","LU2462157665.USD","LU1093756168.USD","LU1868837136.USD","IE00BVYPNW00.USD","LU0683600562.USD","LU0210536198.USD","LU1983299246.USD","LU0158827948.USD","LU0787776722.HKD","LU1712237335.SGD","LU1496350502.SGD","SG9999015986.USD","IE0009355771.USD","LU2361045086.USD","LU0128525689.USD","IE00BFSS7M15.SGD","LU2471134796.USD","IE0002270589.USD","SG9999014914.USD","LU1868836914.USD","LU0511384066.AUD","LU1629891620.HKD","IE00BN8TJ469.HKD","LU1023059063.AUD","LU0949170772.SGD","LU1066051498.USD","LU2357305700.SGD","LU1037948541.HKD","LU2265009873.SGD","SG9999015952.SGD","LU0079474960.USD","LU0471298694.HKD","LU0289739343.SGD","LU2129689605.HKD","IXJ","CRCL","LU0964807845.USD","LU2213496289.HKD","LU1430594728.SGD","LU1732800096.USD","LU2361044949.HKD","IYH","LU1718418525.SGD","RXL","LU1720051017.SGD","IE00B4JS1V06.HKD","LU0133085943.USD","PBE","LU2112291526.USD","FTXH","LU1804176565.USD","LU2237443978.SGD","LU0471298777.SGD","LU1035775433.USD","BK4559","IE00BJJMRZ35.SGD","IE00BFMHRM44.USD","BK4583","LU0170899867.USD","LU2129689514.USD","IE00BKDWB100.SGD","LU1814569148.SGD","IE00BLSP4452.SGD","LU1720051108.HKD","LU0211327993.USD","LU0320765059.SGD","LU0345770993.USD","LU0689626769.HKD","LU1548497426.USD","DAL","LU0820561909.HKD","LU0795875086.SGD","LU1585245621.USD","AGNG","GDOC","LU2357627491.SGD","LU1934455863.HKD","IHE","BK4139","MEDI","LU1145028129.USD","LU0203201768.USD","LU1267930227.SGD","LU1037948897.HKD","CRCG","LU1861220207.SGD","MEDX","LU0672654240.SGD","LU0203345920.USD","IE0002141913.USD","LU2264538146.SGD","LU2211815571.USD","LU2324357040.USD","LU1057294990.SGD","BK4550","LU0786609619.USD","BK4578","LU0203202063.USD","IE00BFSS8Q28.SGD","IE00B4R5TH58.HKD","BK4585","LU1066053197.SGD","LU1244550577.SGD","PJP","LU1244550221.USD","IBB","IE00BN29S564.USD","LU2602419157.SGD","WDNA","LU0345770308.USD","LU2471134952.CNY","BK4516","LU1868836591.USD","IE00BZ1G4Q59.USD","SG9999001176.SGD","LU0069063385.USD","LU0708994859.HKD","LU1989771016.USD","LU2347655156.SGD","LU0985320562.USD","LU0942090050.USD","SG9999014880.SGD","IE00BK4W5M84.HKD","LU2028103732.USD","LU2491050154.USD","LU0823434583.USD","LU0943347566.SGD","LU1323610961.USD","IE00BVYPNV92.GBP","LU0965509283.SGD","LU0289739699.SGD","LU0061475181.USD","LU1974910355.USD","IE000MB6IJN5.SGD","LU0354030438.USD","LU0795875169.SGD","LU1732799900.SGD","BK4007","LLY","LU1061106388.HKD","SG9999015978.USD","GB00BDT5M118.USD","LU0868494708.USD","LU2552382058.USD","IBBQ","LU2087621335.USD","LU0158827781.USD","LU0432979614.USD","IE00BSNM7G36.USD","LU1496350171.SGD","LU2108987350.USD","CCUP","LU2237443382.USD","IE00BKPKM429.USD","IE0005OL40V9.USD","LU2360106947.USD","LU0417517546.SGD","LU2237443549.SGD","LU0289961442.SGD","BK4500","IE000F7OJYX1.SGD","IE000WAW04H5.SGD","XLV","LU2491049909.HKD","IE00BJT1NW94.SGD","LU2471134879.HKD","LU2089283258.USD","LU0203347892.USD","IE00BBT3K403.USD","LU1623119135.USD","LU2111349929.HKD","LU1280957306.USD","IE00BFTCPJ56.SGD","LU1668664300.SGD","LU1868836757.USD","BK4568","IE00BJJMRY28.SGD","LU0238689110.USD","LU0472753341.HKD","LU2552382215.SGD","BK4008","LU0466842654.USD","LU1674673691.USD","BK4532","SG9999017495.SGD","LU1267930730.SGD","LU2750360997.AUD","LU2491050071.SGD","LU0320765992.SGD","SG9999018857.SGD","LU2237443465.HKD","LU0820561818.USD","IE00BDGV0183.EUR","LU0868494617.USD","LU1861217088.USD","LU1551013342.USD","LU2237438978.USD","LU1267930490.SGD","LU1791807156.HKD","BIIB","LLYX","SKHYV","ILDR","BBH","LU2361044865.SGD","LU2063271972.USD","BIB","LU0385154629.USD","LU0965509101.SGD","LU1989772840.SGD","LU0323591593.USD","CANC","SG9999014898.SGD","LU0661504455.SGD","LU2089284900.SGD","LU0106261372.USD","VHT","LU0310800965.SGD","LU1571399168.USD","IE00BLSP4239.USD","LU0553294199.USD","LU0234572021.USD","FHLC","LU0234570918.USD","HRTS","LU2089984988.USD","LU0058720904.USD","IE0001KFT4U8.USD","SGXZ99366536.SGD","LU0225283273.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650718438","title":"滙豐表示，生物製藥領域的併購交易有望創下年度新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2650718438","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650718438?lang=zh_tw&edition=fundamental","pubTime":"2026-07-10 18:33","pubTimestamp":1783679616,"startTime":"0","endTime":"0","summary":"BUZZ-汇丰表示，生物制药领域的并购交易有望创下年度新高7月10日-** 汇丰表示，生物制药领域的并购活动“正朝着创纪录的一年迈进”** 该券商指出，随着核心药品面临专利压力，大型制药企业正通过并购 (link) 来强化产品管线，并缓解对未来增长的担忧** 报告指出，截至4月，吉利德科学公司（GILD.O）在三笔收购中支付了约110亿美元的预付款；截至5月，礼来公司（LLY.N）的收购支出超过1","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nL4T43C0Q7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0786609619.USD","WDNA","RXL","LLII","MEDX","BIIB","LLYX","XLV","MEDI","BIB","AGNG","IXJ","NUVL","FTXH","PJP","LU0795875086.SGD","FHLC","LU0683600562.USD","BBH","LU1267930730.SGD","LU1267930573.SGD","LU1804176565.USD","ELIS","LU2646069778.SGD","CURE","PBE","IBBQ","GDOC","VHT","LLY","PPH","LLYZ","GILD","GSK.UK","OZEM","LU1323610961.USD","LU0820561909.HKD","IBB","THNR","LU1934455277.USD","BK5011","BMED","ELIL","HRTS","ILDR","JDOC","IHE","IYH","ABBV","CANC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167833053","title":"阿爾尼拉姆製藥公司股價大漲15.5%，因阿斯利康神經疾病藥物Wainua心臟病後期試驗失敗","url":"https://stock-news.laohu8.com/highlight/detail?id=1167833053","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167833053?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 21:35","pubTimestamp":1783604157,"startTime":"0","endTime":"0","summary":"阿尔尼拉姆制药公司股价飙升超过15%，这一显著涨幅源于其竞争对手阿斯利康的一款药物在关键临床试验中遭遇挫折。阿斯利康与合作伙伴Ionis Pharmaceuticals开发的神经疾病治疗药物Wainua，在一项针对特定心脏病患者的后期研究中未能达到主要目标。\n市场对此反应迅速，投资者将目光投向了阿尔尼拉姆。该公司拥有针对相似适应症的在研药物，此次竞争对手的试验失利，被广泛视为为阿尔尼拉姆的产品扫清了潜在的竞争障碍，或至少推迟了其面临的直接市场挑战。这一事件凸显了生物制药领域激烈的竞争动态，单一临床结果足以引发相关公司市场估值的剧烈波动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU0320765992.SGD","LU0114720955.EUR","PBE","BK4585","BK4548","BK4588","BK4139","LU0882574055.USD","LU0109394709.USD","ALNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650913850","title":"福泰製藥(VRTX)股票7月8日盤中下跌3.09%：投資者必看的核心信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2650913850","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650913850?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 02:15","pubTimestamp":1783534535,"startTime":"0","endTime":"0","summary":"• Vertex Pharmaceuticals已同意以100亿美元现金收购Crinetics Pharmaceuticals。\n• 此次收购溢价超过Crinetics股价的100%。\n• 在估值创历史新高期间，高管们根据预先安排的交易计划出售了公司股票。","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262018348-market-movers-vrtx-20260708","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1430594728.SGD","BIB","IE00B19Z9P08.USD","LU0058720904.USD","LU0079474960.USD","SG9999013999.USD","BK4139","IE00B19Z9Z06.USD","IBB","LU1093756168.USD","BBH","LU2237438978.USD","SG9999001176.USD","LU1035775433.USD","LU1069344957.HKD","IE00B19Z3581.USD","LU2417539215.USD","LU0889565916.HKD","IE00B19Z3B42.SGD","LU0289739699.SGD","IDNA","IE00BJJMRZ35.SGD","LU1674673428.USD","LU2362541273.HKD","SGXZ57979304.SGD","IE00BJT1NW94.SGD","LU1778281490.HKD","VRTX","LU0432979614.USD","IE0002270589.USD","IBBQ","IE00BFTCPJ56.SGD","LU0234570918.USD","IE00B2B36J28.USD","IE0002141913.USD","LU1585245621.USD","LU2462157665.USD","LU1093756325.SGD","LU2324357040.USD","PBE","LU1674673691.USD","LU0417517546.SGD","BK4532","LU2362540622.SGD","IE00BZ9MQY76.HKD","LU2362541513.USD","IE00B4R5TH58.HKD","BK4585","IE00B894F039.SGD","SG9999001176.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649299398","title":"大摩解讀福泰製藥百億收購Crinetics：補齊內分泌管線佈局 兩大核心藥物打開增長空間","url":"https://stock-news.laohu8.com/highlight/detail?id=2649299398","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649299398?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 20:01","pubTimestamp":1783512080,"startTime":"0","endTime":"0","summary":"摩根士丹利发布研报，对福泰制药以100亿美元收购Crinetics的交易进行解读。此次收购将为福泰制药新增第五大业务支柱——内分泌药物，补齐公司管线布局。根据公告，每股85美元的收购价格较Crinetics周一的收盘价溢价了102%。值得注意的是，摩根士丹利担任福泰制药的财务顾问，协助该公司达成收购Crinetics的协议。","market":"us","thumbnail":"https://community-static.tradeup.com/news/7870ada20f73cf52a4a0efa576cd369c","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/7870ada20f73cf52a4a0efa576cd369c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1464871.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"大摩解读福泰制药(VRTX.US)百亿收购Crinetics：补齐内分泌管线布局 两大核心药物打开增长空间","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4533","LU1720051017.SGD","LU2237438978.USD","IE00B19Z3581.USD","BK4588","LU2236285917.USD","LU1791710400.SGD","LU2133065610.SGD","BIB","LU0079474960.USD","LU1720051108.HKD","IE0002141913.USD","IBB","LU0882574139.USD","LU0528227936.USD","LU1585245621.USD","LU2089284900.SGD","LU2362540622.SGD","LU2487616109.SGD","LU0267386448.USD","LU0210528500.USD","SG9999001176.USD","IDNA","LU1732799900.SGD","IE00BZ9MQY76.HKD","IAI","LU2111349929.HKD","IE00B19Z9P08.USD","LU0053666078.USD","LU1674673691.USD","IBBQ","IE0009355771.USD","LU1363072403.SGD","LU0058720904.USD","LU0109394709.USD","BK4581","LU1244550221.USD","VRTX","KBWB","PBE","LU2456880835.USD","LU0432979614.USD","IE0002270589.USD","BK4139","LU2362541273.HKD","LU0823416689.USD","BBH","IE00B894F039.SGD","LU0390134368.USD","LU0098860793.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649969921","title":"RBC Capital上調福泰製藥目標價至570美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2649969921","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649969921?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 16:24","pubTimestamp":1783499090,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4585","VRTX","LU0708994859.HKD","LU2362540622.SGD","LU0029864427.USD","IE00B2B36J28.USD","BK4532","IE00BJJMRZ35.SGD","IE00B894F039.SGD","BK4207","UDN","LU1267930573.SGD","IE00B19Z9Z06.USD","IE00B19Z3B42.SGD","SG9999001176.USD","LU0058720904.USD","IBB","IE00B19Z9P08.USD","LU1778281490.HKD","LU2456880835.USD","PBE","LU0823416689.USD","LU1069344957.HKD","LU1093756325.SGD","IDNA","GSIB","IBBQ","LU2324357040.USD","LU0128525929.USD","LU2237438978.USD","SGXZ57979304.SGD","IE00BFTCPJ56.SGD","LU2417539215.USD","LU2462157665.USD","LU0310800379.SGD","SG9999013999.USD","LU0234570918.USD","BBH","LU0289739699.SGD","LU1093756168.USD","BK4567","LU0320765992.SGD","RY","BK4533","IE00B4R5TH58.HKD","BIB","LU0417517546.SGD","BK4139","UUP","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649952006","title":"（活力中國調研行）上海生物醫藥產業規模破萬億 張江藥谷青年人才成創新藥研發主力","url":"https://stock-news.laohu8.com/highlight/detail?id=2649952006","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649952006?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 11:56","pubTimestamp":1783482969,"startTime":"0","endTime":"0","summary":"中新网上海7月8日电(杨海燕马佳佳)“我们对青年人才‘如饥似渴’，上海团队有180多名全职员工，90%以上都是40岁以下的青年人才。”英硅智能全球对外合作负责人、副总裁王珏7日在“活力中国调研行”主题采访活动中介绍道。在上海张江药谷，这片曾经的农田已崛起为世界级生物医药创新高地，而活跃其中的青年人才，正成为推动创新药研发的主力军。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607083798154946.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607083798154946.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["XBI","IBB","GSKH","PBE","161726","BBP","BK4588","BK4585","GDOC","LFSC","SBIO","WRND","BK4581","399441"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111378876","title":"Vera Therapeutics股價飆升：腎病新藥獲FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1111378876","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111378876?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 02:47","pubTimestamp":1783450047,"startTime":"0","endTime":"0","summary":"周二，Vera Therapeutics, Inc.的股价上涨约8%，此前美国食品药品监督管理局批准了其用于治疗IgA肾病的药物。这款名为Trutakna的药物通过阻断两种蛋白质来发挥作用，这两种蛋白质会促使免疫系统产生抗体，这些抗体在肾脏中积聚并造成损伤。这是美国首个获批同时靶向这两种蛋白质的药物，尽管已有其他几种药物治疗该疾病。福泰制药正在研发一种同样能阻断这两种蛋白质的类似药物，FDA预计将在今年晚些时候对此做出裁决。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","IE00B19Z9Z06.USD","LU1674673691.USD","LU2362541273.HKD","LU0289739699.SGD","LU2362541513.USD","IE00BJJMRZ35.SGD","LU2362540622.SGD","IE00B4R5TH58.HKD","LU0823416689.USD","IBB","LU1674673428.USD","LU1778281490.HKD","BK4532","BK4533","LU1093756168.USD","IE00B19Z3581.USD","IE00B19Z9P08.USD","IE00BJT1NW94.SGD","SG9999001176.USD","LU2324357040.USD","SG9999013999.USD","BK4539","VRTX","SGXZ57979304.SGD","LU0889565916.HKD","LU0432979614.USD","BK4588","BK4139","BK4585","LU0234570918.USD","VERA","IE00B19Z3B42.SGD","LU0256863811.USD","LU1069344957.HKD","IDNA","LU0061475181.USD","BIB","LU2456880835.USD","LU2417539215.USD","LABU","IE00B2B36J28.USD","LU0109394709.USD","BK4567","LU2236285917.USD","BBH","IE00BFTCPJ56.SGD","LU0417517546.SGD","LU0079474960.USD","IE00BZ9MQY76.HKD","LU0320765992.SGD","IE00B894F039.SGD","PBE","IE0009355771.USD","IE0002141913.USD","LU1035775433.USD","IE0002270589.USD","LU2237438978.USD","SG9999001176.SGD","LU1430594728.SGD","IBBQ","LU1093756325.SGD","LU2462157665.USD","LU1585245621.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649398479","title":"數據簡報-隨着競爭日趨激烈，減肥藥開發商紛紛搶佔這一利潤豐厚的市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2649398479","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649398479?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 23:45","pubTimestamp":1783439113,"startTime":"0","endTime":"0","summary":"数据简报-随着竞争日趋激烈，减肥药开发商纷纷抢占这一利润丰厚的市场修改发稿日期；新增Viking Therapeutics和Kailera Therapeutics路透7月7日-减肥药市场正蓬勃发展，生物技术公司竞相争夺这一快速增长领域的市场份额，该领域目前主要由诺和诺德和礼来主导。辉瑞补充称，其目标是在2028年在这个快速增长的减肥药市场中获得首项批准。2024年的数据显示，在一项为期一年的中期临床试验中，MariTide帮助超重患者减重高达20% 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nL4T4391HA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2063271972.USD","LU0158827948.USD","LU2471134879.HKD","LU2237443895.HKD","LU1934455277.USD","LU2237443978.SGD","LU0861579265.USD","BK4559","LU2417539215.USD","IE0004445239.USD","LU2168564495.EUR","IE00BN8TJ469.HKD","LU0708995401.HKD","IE00BKPKM429.USD","ILDR","LU2468319806.SGD","PJP","IE00BFTCPJ56.SGD","SG9999001440.SGD","SGXZ31699556.SGD","LU2111349929.HKD","GB00BDT5M118.USD","LU0094547139.USD","LU0225771236.USD","LU0965509283.SGD","LU0320765059.SGD","LU0353189763.USD","PAWZ","LU2265009873.SGD","LU1917777945.USD","THNR","JDOC","SGXZ57979304.SGD","LU2324357040.USD","LU1934455194.USD","04332","LU2360032135.SGD","LU0070302665.USD","LU2168564065.EUR","SG9999014880.SGD","IE00BK4W5M84.HKD","LU0234572021.USD","IE0001KFT4U8.USD","LU2491049909.HKD","LU0965509010.AUD","LU2361044949.HKD","LU0316494557.USD","LU2237443465.HKD","IE00B1XK9C88.USD","LU0466842654.USD","SG9999014559.SGD","LU0321505868.SGD","OZEM","BIB","IE00BFSS8Q28.SGD","LU0058720904.USD","LU2125909593.SGD","LU1883839398.USD","IE00BK4W5L77.USD","LU1037948541.HKD","SG9999015945.SGD","SG9999018865.SGD","MEDX","LU0079474960.USD","LU2746668461.USD","LU0306806265.USD","LU1989772923.USD","SG9999001176.USD","IE00BJJMRX11.SGD","LU1941712264.USD","LU0985320562.USD","IE00BJJMRY28.SGD","LU1127390331.HKD","SG9999002224.SGD","BK4592","BK4007","LU1983299246.USD","BK4585","SG9999014914.USD","FTXH","LU1551013425.SGD","LU1280957306.USD","SG9999014575.USD","LU1430594728.SGD","LU0823434583.USD","LU0820562030.AUD","IE00B19Z3581.USD","AMGN","LU0683600562.USD","IE00BWXC8680.SGD","LU0882574139.USD","BK4139","IE00B4JS1V06.HKD","LU0109391861.USD","LU2236285917.USD","IE0009355771.USD","XLV","LU0432979614.USD","LU2237438978.USD","LU2471134796.USD","LU2896262040.SGD","LU0130517989.USD","LU0354030511.USD","LLYX","LU1868837300.USD","LU2112291526.USD","NVO","LU0823434740.USD","LU1720051017.SGD","LU1974910355.USD","LU1116320737.USD","LU1623119135.USD","LU1035773651.USD","LU2087625088.SGD","LU1093756325.SGD","BMED","LU1585245621.USD","IHE","IE00B775H168.HKD","LU1366192091.USD","LU1988902786.USD","IE00BZ1G4Q59.USD","LU0353189680.USD","LU0980610538.SGD","LU0306807586.USD","SG9999011175.SGD","LU2023250330.USD","LU1934455863.HKD","LU1894683348.USD","LU2028103732.USD","LU0203345920.USD","LU2471134952.CNY","LU0889565916.HKD","LU0354030438.USD","LU1571399168.USD","IE00B1BXHZ80.USD","IE00BFSS7M15.SGD","LLYZ","LU1699723380.USD","LU1989771016.USD","LU0942090050.USD","LU0198837287.USD","LU0158827781.USD","LU2089283258.USD","LU2089984988.USD","LU1712237335.SGD","BBH","BK4566","LU0640476718.USD","LU2471134523.USD","LU2552382132.HKD","PFE","LU0385154629.USD","IE00BLSP4239.USD","IE00B3T34201.USD","IE00BSNM7G36.USD","LU0225284248.USD","LU0208291251.USD","LU2242646821.SGD","BK4533","LU0786609619.USD","LLY","IE0005OL40V9.USD","LU2023251221.USD","SG9999003800.SGD","LLII","NVOH","LU0323591593.USD","CANC","LU0859254822.USD","BK4599","LU0345770308.USD","SG9999018857.SGD","LU0265550359.USD","IE00BKVL7J92.USD","BK4516","IE00B7KXQ091.USD","LU2213496289.HKD","SG9999015986.USD","LU0097036916.USD","LU2433249047.HKD","LU0985481810.HKD","LU1064131342.USD","MRK","LU0345770993.USD","LU1069347547.HKD","LU0964807845.USD","LU0154236417.USD","LU0266013472.USD","LU0868494708.USD","LU1093756168.USD","LU2023250843.SGD","LU1066051225.USD","ELIL","LU2750360641.GBP","LU0882574055.USD","BK4581","LU2360106947.USD","LU0868494617.USD","LU0965508806.USD","LU0256863902.USD","LU1868836757.USD","SG9999001176.SGD","LU2242652126.USD","LU2023250504.SGD","BK4550","LU1116320901.HKD","LU0417517546.SGD","LU0689472784.USD","SG9999015978.USD","LU0225283273.USD","IE0002141913.USD","LU2264538146.SGD","LU1720051108.HKD","BK4532","LU0238689110.USD","IE0004445015.USD","LU0477156953.USD","PPH","LU0203202063.USD","IBB","VHT","LU1145028129.USD","SG9999013999.USD","SGXZ81514606.USD","ELIS","HRTS","BK4588","LU2750360997.AUD","LU1201861249.SGD","IXJ","LU0114720955.EUR","LU0122379950.USD","LU0210536198.USD","LU1923622614.USD","LU0130102774.USD","GDOC","SG9999014906.USD","LU2361044865.SGD","LU2756315664.SGD","LU2125909247.SGD","LU2089284900.SGD","IYH","SGXZ51526630.SGD","LU2462157665.USD","LU2602419157.SGD","LU2746668974.SGD","IE00BJJMRZ35.SGD","SG9999014898.SGD","LU2168564222.USD","LU1291159041.SGD","NVOX","LU0061475181.USD","FHLC","CURE","LU0320765646.SGD","IE00BN29S564.USD","LU2456880835.USD","LU0106261372.USD","LU0265550946.USD","LU1814569148.SGD","IE00BJLML261.HKD","LU2125154935.USD","LU2108987350.USD","LU1066053197.SGD","LU0965509101.SGD","LU2552382215.SGD","LU0320765992.SGD","LU0320765489.SGD","SG9999002232.USD","LU0256863811.USD","MEDI","LU0170899867.USD","LU2237443549.SGD","LU2168563687.JPY","LU2596442595.SGD","LU2361045086.USD","SGXZ99366536.SGD","LU1037948897.HKD","LU2106854487.HKD","IE00BBT3K403.USD","LU2237443382.USD","IE0002270589.USD","LU2271345857.HKD","AGNG","LU1162221912.USD","LU0471298694.HKD","LU2237443622.USD","LU0006306889.USD","LU0133085943.USD","LU0098860793.USD","03165","LU1066051498.USD","LU2211815571.USD","WDNA","LU0672654240.SGD","LU0203347892.USD","RXL","LU1548497426.USD","LU0787776722.HKD","LU1868837136.USD","LU1629891620.HKD","SG9999015358.SGD","LU0471298777.SGD","LU0096364046.USD","LU1323610961.USD","LU1035775433.USD","IE00BLSP4452.SGD","LU2168564149.EUR","BK4568","LU0321505439.SGD","SG9999017495.SGD","LU1941712348.USD","SG9999014567.USD","LU2357627491.SGD","SG9999014542.SGD","LU0648001328.SGD","LU1929549753.HKD","IE00BJT1NW94.SGD","LU0820561909.HKD","LU0823416689.USD","IE00B2B36J28.USD","BK4534","LU0109394709.USD","LU1804176565.USD","LU0211331839.USD","LU1868836914.USD","LU1057294990.SGD","RHHBY","LU2552382058.USD","IE000M9KFDE8.USD","PBE","LU0203201768.USD","LU1023059063.AUD","LU2491050154.USD","LU2357305700.SGD","LU1232071149.USD","LU1061106388.HKD","LU2461242641.AUD","SG9999015341.SGD","LU0289739699.SGD","LU1069344957.HKD","IE00BKDWB100.SGD","IBBQ","LU0943347566.SGD","SG9999015952.SGD","LU1551013342.USD","LU0820561818.USD","LU1267930730.SGD","LU2125154778.USD","IE00B4R5TH58.HKD","LU0456855351.SGD","LU1989772840.SGD","LU1868836591.USD","LU1066051811.HKD","LU2491050071.SGD","LU2756315318.SGD","IE00B19Z3B42.SGD","LU1894683264.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":7,"totalSize":152,"code":"91000000","status":"200"}]}}